The pervasive integration of artificial intelligence (AI) into modern work processes is a transformative wave impacting industries globally. However, a significant hurdle often encountered by HR leaders is employee resistance, a sentiment particularly pronounced within the healthcare sector. Physicians, accustomed to established clinical practices and possessing a deep-seated commitment to patient autonomy, can exhibit considerable skepticism towards new technologies that alter their workflow. This reality, according to Jim McGee, chief people officer at the health network Akido, presents a dual landscape of formidable challenges and compelling opportunities.
Akido, a pioneering health network operating across California, Rhode Island, and New York, serves approximately half a million patients through its more than 240 physicians. McGee, who joined the organization three years ago, has been instrumental in its evolution into what is recognized as the nation’s first AI-native health system. This transformation is largely driven by Akido’s proprietary tool, ScopeAI. This advanced AI platform is designed to conduct a comprehensive clinical investigation before a physician engages with a patient. By analyzing vast datasets and patient histories, ScopeAI offers preliminary recommended diagnoses and potential care plans, thereby augmenting the physician’s diagnostic and treatment capabilities.
"We’ve learned a great deal about what it takes to lead this kind of change," McGee stated, reflecting on the journey. He emphasized that Akido’s approach has been deeply rooted in active listening and a commitment to a shared purpose: identifying the most critical challenges faced by clinicians and strategically leveraging AI to address them. This foundational principle has been critical in fostering acceptance and encouraging adoption among a traditionally cautious professional group.
The core philosophy underpinning Akido’s AI integration is clear: "We are not looking to replace doctors, but to use AI to reduce the cognitive load and give physicians better information to make better decisions," McGee explained. He articulated a vision where AI enhances, rather than diminishes, the human aspect of healthcare. "Ultimately, AI should make healthcare more human, not less. If we can take work and cognitive burden away from our clinicians, they can spend more time doing what only they can do—listening, exercising judgment, and caring for the person in front of them." This perspective directly addresses the physician’s primary concern: maintaining the doctor-patient relationship and preserving the nuanced art of medicine.
Building a Strategic Foundation for AI Adoption
A successful organizational transformation, McGee asserted, must commence with a clearly defined and universally understood common purpose. For Akido, this meant ensuring that physicians and staff alike recognized how AI integration would ultimately contribute to delivering superior patient care. "Expanding access to high-quality care is our north star," McGee reiterated. "AI is not the goal; it’s a tool to help us get there." This framing positions AI as a means to an end, rather than an end in itself, thereby aligning technological advancement with the core mission of healthcare.
The process of dismantling resistance to AI adoption was strategically orchestrated through several key initiatives. A pivotal element was the engagement of "super users"—physicians who embraced the technology early on. These early adopters played an integral role in co-designing workflows, piloting the ScopeAI tool, and subsequently becoming influential advocates for its adoption among their peers. Their firsthand experience and endorsement provided invaluable social proof and helped demystify the technology for more hesitant colleagues.
This physician-led initiative was further bolstered by close collaboration between Akido’s product and engineering teams and the physicians themselves. These teams worked "at the elbow" of clinicians, providing immediate support, gathering feedback, and making iterative improvements to the AI system in real-time. "These working relationships build trust, and trust allows us to have honest conversations when things aren’t working," McGee remarked. This hands-on, collaborative approach fostered a sense of partnership and mutual respect, essential for navigating the complexities of introducing a novel technological paradigm into a sensitive professional environment.
To ensure continuous alignment with clinical realities and to challenge potential biases or oversights within the AI development process, Akido also established its Clinical AI Advisory Council. This council comprises Akido’s medical directors alongside external clinical experts. Their collective mandate is to scrutinize the AI’s performance, "challenge assumptions and stay grounded in what actually matters in patient care." This multidisciplinary oversight mechanism provides a crucial safeguard against the potential for technology to diverge from the practical demands and ethical considerations of frontline medical practice.
Measuring the success of ScopeAI extends beyond mere adoption rates. Akido employs a dual approach, incorporating both quantitative and qualitative metrics. Quantitatively, they assess physician engagement with optional features and explore emergent use cases, indicating the tool’s adaptability and value. Qualitatively, they gauge whether physicians understand and believe in the product roadmap, signifying a deeper level of buy-in and strategic alignment. However, McGee underscored the ultimate benchmark: "The ultimate measure is patient care. Are we improving access and quality? Are we delivering better outcomes? Ultimately, AI adoption only matters if it translates to better patient care." This patient-centric evaluation framework reinforces the organization’s commitment to its core mission.
AI Adoption: A Leadership Imperative Across Industries
Akido’s experience in integrating advanced AI technology offers a compelling case study that resonates across various sectors. The integration of AI is not solely a technical challenge; it is fundamentally a leadership challenge, as highlighted by McGee. While the technology itself is critical, effective change management is equally, if not more, important. Leadership serves as the essential bridge connecting these two crucial components.
For C-suite executives, McGee advised that AI adoption must be viewed as a comprehensive business transformation, not merely a technology implementation. The true potential lies not in augmenting existing workflows with AI, but in leveraging AI to fundamentally reimagine the business model and the very nature of how work is accomplished. This requires a strategic foresight that looks beyond immediate operational gains to long-term organizational evolution.
McGee drew a parallel between the healthcare sector and broader organizational AI adoption, suggesting that just as patients desire more quality time with their physicians, employees seek more meaningful interactions with their leaders. In both scenarios, valuable time is often consumed by "lower-value work." The advent of AI, McGee posited, offers a powerful solution. "If AI can take away some of that burden, it creates more capacity for what matters, like coaching, feedback, development, and helping the business navigate change. If we get this right, AI should make work more human, not less." This optimistic outlook suggests that AI, when thoughtfully implemented, can lead to a more engaged workforce and a more empathetic patient experience.
The implications of Akido’s pioneering work extend beyond its immediate operational impact. The health network’s success in navigating physician skepticism and integrating AI as a supportive tool rather than a replacement mechanism offers a blueprint for other organizations grappling with similar challenges. The emphasis on shared purpose, physician empowerment through co-creation, and a patient-centric evaluation framework are crucial takeaways.
Background Context of AI in Healthcare:
The integration of AI into healthcare has been a topic of intense discussion and development for years. Early applications focused on areas like medical imaging analysis, drug discovery, and administrative task automation. However, the widespread adoption of AI directly within clinical decision-making processes, as Akido is pursuing with ScopeAI, represents a more advanced and potentially disruptive phase. Concerns about data privacy, algorithmic bias, regulatory hurdles, and the impact on the physician’s role have historically slowed down comprehensive integration. Akido’s proactive approach to addressing physician sentiment and demonstrating tangible benefits is therefore significant in this evolving landscape.
Timeline of Akido’s AI Integration (Inferred):
- Prior to McGee’s Arrival (3 years ago): Akido was a traditional health network with established clinical practices.
- McGee’s Tenure Begins: A strategic initiative to explore and integrate AI into core operations is launched, focusing on enhancing patient care.
- Development of ScopeAI: The AI tool is conceptualized, developed, and refined through extensive research and development, including early clinical testing.
- Pilot Programs and Physician Engagement: ScopeAI is introduced to a select group of physicians, with a focus on gathering feedback and building early champions (super users).
- Establishment of the Clinical AI Advisory Council: Formalized governance and oversight structure is created to ensure ethical and effective AI implementation.
- Rollout and Iterative Improvement: ScopeAI is progressively integrated into wider clinical workflows, with ongoing "at the elbow" support and continuous system updates based on user feedback and performance data.
- Recognition as AI-Native Health System: Akido achieves a significant milestone by being recognized as the first AI-native health system in the country, signifying deep integration across its operations.
Supporting Data and Industry Trends:
While specific quantitative data on ScopeAI’s impact at Akido was not provided in the original content, broader industry trends offer supporting context. A 2023 report by Accenture projected that AI in healthcare could generate annual savings of up to $200 billion in the U.S. alone, primarily through operational efficiencies and improved patient outcomes. Furthermore, studies have indicated that physicians spend a significant portion of their time on administrative tasks and electronic health record (EHR) management, often cited as a major contributor to burnout. AI tools like ScopeAI aim to alleviate this burden, potentially freeing up valuable time for direct patient interaction. A survey by the American Medical Association in 2022 found that physician burnout remains a critical issue, with EHR burden being a primary driver. AI’s potential to reduce this burden is therefore a key motivator for adoption.
Reactions from Related Parties (Inferred):
While direct quotes from external parties were not included, the article’s framing suggests that Akido’s approach would likely garner positive attention from healthcare futurists, technology investors, and patient advocacy groups who are keen on innovations that improve healthcare access and quality. Conversely, some medical ethicists might continue to emphasize the need for robust human oversight and validation of AI-driven recommendations, a concern that Akido appears to address through its advisory council. Regulatory bodies would also be closely observing such implementations to ensure patient safety and data security standards are met.
Analysis of Implications:
Akido’s success in fostering AI adoption among its physician population has significant implications for the broader healthcare industry. It demonstrates that technological advancement, particularly in a field as sensitive and human-centric as medicine, is profoundly dependent on a people-first strategy. By prioritizing physician concerns, focusing on augmenting rather than replacing human expertise, and building trust through collaborative engagement, Akido offers a viable model for overcoming resistance to AI.
The "AI-native" designation suggests a deep integration that goes beyond simply layering AI onto existing systems. It implies a fundamental redesign of processes, workflows, and even organizational culture to leverage AI’s capabilities at every level. This proactive and holistic approach could set a new benchmark for how health systems approach digital transformation.
Furthermore, the emphasis on making healthcare "more human" through AI is a powerful counterpoint to concerns that technology might depersonalize patient care. By enabling physicians to dedicate more time to empathetic interaction, critical thinking, and personalized care, Akido’s model suggests that AI can, in fact, amplify the human element in medicine. This is a crucial message for both healthcare providers and patients alike as the technology continues to evolve. The long-term success of such integrations will hinge on continuous adaptation, rigorous evaluation, and an unwavering commitment to the core values of patient well-being and ethical practice.
Learn more about leading through AI transformation during a keynote at HR Tech from Kelly Jones, chief people officer at Cisco. In her Oct. 20 address, Jones will speak to how HR can lead with clarity and resilience amid ongoing transformation. Click here to register.
